Applus+ has acquired De.Testing, a leading medical device testing company in China, to enhance its capabilities and expand its presence in the growing medical device market.
Information on the Target
De.Testing, founded in 2019, is a prominent medical device testing company based in China. The company specializes in various sectors, including orthopaedics, dentistry, and medical device software. De.Testing is known for providing high-quality testing services and customizable technical solutions tailored to the needs of its clients. Additionally, it holds several prestigious accreditations, including the China Metrology Accreditation (CMA), the China National Accreditation Service for Conformity Assessment (CNAS), and the International Accreditation Service (IAS), enhancing its credibility in the medical device industry.
This acquisition not only bolsters Applus+'s service offerings but also positions it favorably in a rapidly expanding market that is increasingly demanding comprehensive testing solutions for medical devices.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
China's medical device industry has seen remarkable growth in recent years, driven by rising healthcare expenditure, an aging population, and increasing demand for advanced medical techn
Similar Deals
Adicon Holdings Limited → Crown Bioscience Inc.
2026
Applus+
invested in
De.Testing
in 2025
in a Other deal